• Features of treatment in women of postmenopause with intrauterine fluid
en To content

Features of treatment in women of postmenopause with intrauterine fluid

HEALTH OF WOMAN. 2019.6(142): 56–59; doi 10.15574/HW.2019.142.56

А. Kuzminа
Bogomolets National Medical University, Kiev

The article presents data on the characteristics of the species composition of the microflora of the vagina of postmenopausal women with intrauterine fluid and developed an algorithm for treating this group of patients.
The objective: is to study the species composition of the microflora of the vaginal contents in postmenopausal women with intrauterine fluid and based on these data on the development of a treatment algorithm.
Materials and methods. The study was conducted for postmenopausal women with intrauterine fluid, who received the contents of the vagina with subsequent referral for microbiological examination. Then the patients were divided into groups to study the effectiveness of complex treatment. In the first group, two-stage treatment was carried out, including etiotropic treatment and the use of vaginal capsules with promestrin. In group II, only etiotropic treatment was performed.
Results. As a result of microbiological analysis of the vaginal contents, the patients were divided into 3 groups depending on the microecology of the vagina: with atrophic colpitis 35 (52.2%), with bacterial vaginosis 26 (38.8%), with conditional normocenosis 6 (8.9%). Conducted treatment in groups and evaluation after 1–3–6 months. After 6 months of treatment, in groups I and II, a decrease in UPM by 85% and 47%, respectively, was found, and an increase in the contamination of the vaginal contents with lactobacilli by 87% and 43%, respectively (p<0.05), was also detected.
Conclusion. In postmenopausal women with intrauterine fluid, massive microbial contamination of conditionally pathogenic and pathogenic vaginal microflora occurs. Through progressive estrogen deficiency, the unspecific resistance of the vaginal biotope is significantly reduced. The use of intravaginal capsules, which include promestrin, reduces the number of pathogenic and conditionally pathogenic microorganisms in the vagina and thereby reduces the likelihood of developing an ascending infection.
Key words: postmenopausal period, intrauterine fluid, microbiological examination of the vagina, promestrin.

REFERENCES

1. Likhachev VK. 2018. Gynecology. Manual for physicians. Vinnitsa, The New Book: 687

2. Breckenridge JW, Kurtz AB, Ritchie WG et. al. 1982. Postmenopausal uterine fluid collection: indicator of carcinoma. Am J. Roentgenol 139(3):529–534. https://doi.org/10.2214/ajr.139.3.529; PMid:6981319

3. Bronstein J, Auslender R, Pascal B. 1994. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.  J. Reprod. Med 39:674 – 678.

4. Goldstein SR. 1997.The presence of endometrial fluid in asymptomatic postmenopausal women is associated with clinically relevant cervical stenosis. J Ultrasound Med 16(3):208. https://doi.org/10.7863/jum.1997.16.3.208; PMid:9166819

5. Hill K. 1996. The Demography of the Menopause. Maturitas 23:113–127. https://doi.org/10.1016/0378-5122(95)00968-X

6. McCarthy  KA, Hall DA, Kopans DB et. al. 1986. Postmenopausal endometrial fluid collection: always an indicator of malignancy? J. Ultrasound Med. 5(11): 647–649. https://doi.org/10.7863/jum.1986.5.11.647; PMid:3537335

7. Naloboff  K, Pellerito J, Ben-Levi Е. 2001. Imaging the endometrium: disease and normal variants. Radiographics 21(6):1409 –1424.  https://doi.org/10.1148/radiographics.21.6.g01nv211409; PMid:11706213